Monte Rosa Therapeutics Inc (GLUE)

Total Costs & Expenses

$58.10M

Quarterly · Period ending: · USD

GLUE logo

GLUE Total Costs & Expenses

Latest reported$58.10M
GLUE Quarterly Total Costs & Expenses ($4.29M → $58.10M)
High-resolution chart · PNG

GLUE total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monte Rosa Therapeutics Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
58,098,000
54,244,000
52,496,000
45,743,000
38,748,000
40,893,000
47,643,000
35,743,000
37,337,000
36,011,000
34,863,000
36,968,000
37,221,000
34,259,000
32,489,000
28,362,000
27,231,000
24,302,000
23,387,000
19,868,000
18,123,000
11,504,000
11,936,000
6,386,000
5,396,000
4,293,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.